Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Basic Net EPS Stands At $-5.4022

0

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) had an annual basic consolidated EPS of $-5.2884 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $-5.2884.

EPS from continuing operations

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reported $-5.4022 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $-5.4022 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) received basic EPS of $-5.2884 for the annual period ended 2015-12-31. EPS contribution from the parent company was $-5.2884 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $-5.4022 was reported by Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $-5.4022.

Consolidated diluted EPS

For the period ended 2015-12-31, $-5.2884 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $-5.2884 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $-5.4022 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $-5.4022 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $-5.4022 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $-5.4022.

Diluted EPS from parent

Diluted EPS of $-5.2884 was received by Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $-5.2884 on quarterly basis. For the annual period ended 2015-12-31, $-5.4022 was posted by Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $-5.4022 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 2.712. But it was 2.712 for the quarter ended 2015-12-31. 2.712 and 2.712 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 53 times, 1 visits today)